358 related articles for article (PubMed ID: 29632194)
21. Genome-wide CRISPR Screen to Identify Genes that Suppress Transformation in the Presence of Endogenous Kras
Huang J; Chen M; Xu ES; Luo L; Ma Y; Huang W; Floyd W; Klann TS; Kim SY; Gersbach CA; Cardona DM; Kirsch DG
Sci Rep; 2019 Nov; 9(1):17220. PubMed ID: 31748650
[TBL] [Abstract][Full Text] [Related]
22. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
23. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
24. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.
Ezponda T; Dupéré-Richer D; Will CM; Small EC; Varghese N; Patel T; Nabet B; Popovic R; Oyer J; Bulic M; Zheng Y; Huang X; Shah MY; Maji S; Riva A; Occhionorelli M; Tonon G; Kelleher N; Keats J; Licht JD
Cell Rep; 2017 Oct; 21(3):628-640. PubMed ID: 29045832
[TBL] [Abstract][Full Text] [Related]
25. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.
Van der Meulen J; Sanghvi V; Mavrakis K; Durinck K; Fang F; Matthijssens F; Rondou P; Rosen M; Pieters T; Vandenberghe P; Delabesse E; Lammens T; De Moerloose B; Menten B; Van Roy N; Verhasselt B; Poppe B; Benoit Y; Taghon T; Melnick AM; Speleman F; Wendel HG; Van Vlierberghe P
Blood; 2015 Jan; 125(1):13-21. PubMed ID: 25320243
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-Mediated Knock-Out of Kras
Lentsch E; Li L; Pfeffer S; Ekici AB; Taher L; Pilarsky C; Grützmann R
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739488
[TBL] [Abstract][Full Text] [Related]
27. Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation.
Grasso D; Bintz J; Lomberk G; Molejon MI; Loncle C; Garcia MN; Lopez MB; Urrutia R; Iovanna JL
Sci Rep; 2015 Nov; 5():17549. PubMed ID: 26617245
[TBL] [Abstract][Full Text] [Related]
28. UTX - moonlighting in the cytoplasm?
Wiedemuth R; Thieme S; Navratiel K; Dorschner B; Brenner S
Int J Biochem Cell Biol; 2018 Apr; 97():78-82. PubMed ID: 29421189
[TBL] [Abstract][Full Text] [Related]
29. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
[TBL] [Abstract][Full Text] [Related]
30. A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling.
Lin L; Chamberlain L; Pak ML; Nagarajan A; Gupta R; Zhu LJ; Wright CM; Fong KM; Wajapeyee N; Green MR
Cancer Discov; 2014 Oct; 4(10):1168-81. PubMed ID: 25015643
[TBL] [Abstract][Full Text] [Related]
31. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
32. Systematic
Walter DM; Venancio OS; Buza EL; Tobias JW; Deshpande C; Gudiel AA; Kim-Kiselak C; Cicchini M; Yates TJ; Feldser DM
Cancer Res; 2017 Apr; 77(7):1719-1729. PubMed ID: 28202515
[TBL] [Abstract][Full Text] [Related]
33. Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.
Mou H; Moore J; Malonia SK; Li Y; Ozata DM; Hough S; Song CQ; Smith JL; Fischer A; Weng Z; Green MR; Xue W
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3648-3653. PubMed ID: 28320962
[TBL] [Abstract][Full Text] [Related]
34. X chromosome protects against bladder cancer in females via a
Kaneko S; Li X
Sci Adv; 2018 Jun; 4(6):eaar5598. PubMed ID: 29928692
[TBL] [Abstract][Full Text] [Related]
35. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis.
Shukla S; Khan S; Kumar S; Sinha S; Farhan M; Bora HK; Maurya R; Meeran SM
Cancer Prev Res (Phila); 2015 Jun; 8(6):552-62. PubMed ID: 25813524
[TBL] [Abstract][Full Text] [Related]
36. MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response.
Qiu H; Jin BM; Wang ZF; Xu B; Zheng QF; Zhang L; Zhu LY; Shi S; Yuan JB; Lin X; Gao SB; Jin GH
Nat Commun; 2020 Feb; 11(1):1009. PubMed ID: 32081882
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyphenylpyruvate Dioxygenase Is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer.
Du Z; Su J; Lin S; Chen T; Gao W; Wang M; Li Y; Wei D; Hu Z; Gao C; Li Q
Gastroenterology; 2023 Jun; 164(7):1165-1179.e13. PubMed ID: 36813208
[TBL] [Abstract][Full Text] [Related]
38. UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling.
Lei X; Jiao J
Stem Cell Reports; 2018 Apr; 10(4):1193-1207. PubMed ID: 29551674
[TBL] [Abstract][Full Text] [Related]
39. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
[TBL] [Abstract][Full Text] [Related]
40. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]